Ho William Tai-Wei 4

What Happened

• William (Ho) Tai-Wei, a reported 10% owner of IN8BIO (INAB), received a derivative equity award on Feb 4, 2026 for 206,000 shares. The transaction is reported as an award/grant (code A) with an acquisition price of $0.00, meaning no cash was paid at grant.
• This was a grant of a derivative security (e.g., options/RSUs) rather than an open‑market purchase or sale, so it does not represent an immediate buy or sell of outstanding shares.

Key Details

• Transaction date: 2026-02-04; Report filed: 2026-02-06 (timely filing).
• Transaction type/code: Grant/Award (A), derivative acquisition for 206,000 shares at $0.00.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Vesting (per footnote): 25% of the award vests on Feb 4, 2027; the remaining shares vest in 36 equal monthly installments thereafter, contingent on continued service.
• No indication in this filing of an immediate sale, tax withholding, or a 10b5-1 plan.

Context

• This is a company grant to a significant shareholder (10% owner). Grants are common for compensation or incentive purposes and do not by themselves signal a purchase or sale in the market.
• Because the award carries a vesting schedule, the economic interest is subject to future service conditions before the shares become fully owned or transferable.